Samsung Biologics revenue
Samsung Biologics (207940) reported revenue of $3.42 B for fiscal year 2025, +30.3% compared with the year before. Over the last 12 months revenue was $3.85 B.
Revenue 2025$3.42 B
Change+30.3%
World rank#399
Market cap$50.11 B
Revenue by year
By year
| Year | Value | Change |
|---|---|---|
| 2025 | $3.42 B | +30.3% |
| 2024 | $2.63 B | −5.34% |
| 2023 | $2.78 B | +23.1% |
| 2022 | $2.25 B | — |
Converted to US dollars at today’s exchange rate. Data: company filings via Yahoo Finance, updated 2026-11-19. Not investment advice.